|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang JM, Ju BH, Pan CJ, Gu Y, Li MQ, Sun
L, Xu YY and Yin LR: MiR-214 inhibits cell migration, invasion and
promotes the drug sensitivity in human cervical cancer by targeting
FOXM1. Am J Transl Res. 9:3541–3557. 2017.PubMed/NCBI
|
|
4
|
Ellenson LH and Wu TC: Focus on
endometrial and cervical cancer. Cancer Cell. 5:533–538. 2014.
View Article : Google Scholar
|
|
5
|
Yoshikawa H: Progress in the World and
challenges in Japan on HPV vaccination for cervical cancer
prevention. Gan To Kagaku Ryoho. 37:971–975. 2010.(In Japanese).
PubMed/NCBI
|
|
6
|
Ghebre RG, Grover S, Xu MJ, Chuang LT and
Simonds H: Cervical cancer control in HIV-infected women: Past,
present and future. Gynecol Oncol Rep. 21:101–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak Rh, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kozomara A and Griffths-Jones S: miRBase:
Annotating high confdence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu XW, Li L, Li Y and Liu ZH: MiR-153
promotes breast cancer cell apoptosis by targeting HECTD3. Am J
Cancer Res. 6:1563–1571. 2016.PubMed/NCBI
|
|
15
|
Zhou J, Xie M, Shi Y, Luo B, Gong G, Li J,
Wang J, Zhao W, Zi Y, Wu X and Wen J: MicroRNA-153 functions as a
tumor suppressor by targeting SET6 and ZEB2 in ovarian cancer
cells. Oncol Rep. 34:111–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Niu GF, Li B, Sun L and An CG:
MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion
by targeting TGF-β2. PLoS One. 10:e01192252015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zuo J, Wang D, Shen H, Liu F, Han J and
Zhang X: MicroRNA-153 inhibits tumor progression in esophageal
squamous cell carcinoma by targeting SNAI1. Tumor Biol. 2016.(Epub
ahead of print). View Article : Google Scholar
|
|
18
|
Wang Z and Liu C: MiR-153 regulates
metastasis of gastric cancer through Snail1. Tumor Biol. 2015.(Epub
ahead of print).
|
|
19
|
Liu F, Liu B, Qian J, Wu G, Li J and Ma Z:
miR-153 enhances the therapeutic effect of gemcitabine by targeting
SnaiI in pancreatic cancer. Acta Biochim Biophys Sin (Shanghai).
49:520–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shan N, Shen L, Wang J, He D and Duan C:
MiR-153 inhibits migration and invasion of human non-small-cell
lung cancer by targeting ADAM19. Biochem Biophys Res Commun.
456:385–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Pickard K, Jenei V, Bullock MD,
Bruce A, Mitter R, Kelly G, Paraskeva C, Strefford J, Primrose J,
et al: miR-153 supports colorectal cancer progression via
pleiotropic effects that enhance invasion and chemotherapeutic
resistance. Cancer Res. 73:6345–6347. 2013.
|
|
22
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wongfieng W, Jumnainsong A, Chamgramol Y,
Sripa B and Leelayuwat C: 5′-UTR and 3′-UTR regulation of MICB
expression in human cancer cells by novel microRNAs. Gene (Basel).
8:E2132017. View Article : Google Scholar
|
|
25
|
Biegel JM, Henderson E, Cox EM, Bonenfant
G, Netzband R, Kahn S, Eager R and Pager CT: Cellular DEAD-box RNA
helicase DDX6 modulates interaction of miR-122 with the 5′
untranslated region of hepatitis C virus RNA. Virology.
507:231–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao Y, Li X, Wang H, Wen R, He J and Tang
J: Epigenetic regulation of miR-129-2 and its effects on the
proliferation and invasion in lung cancer cells. J Cell Mol Med.
19:2172–2180. 2015.PubMed/NCBI
|
|
27
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu L, Xu Q, Li X and Zhang X: MicroRNA-21
regulates the proliferation and apoptosis of cervical cancer cells
via tumor necrosis factor-α. Mol Med Rep. 16:4659–4663. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng Y, Zou W, Hu C, Li G, Zhou S, He Y,
Ma F, Deng C and Sun L: Modulation of CASC2/miR-21/PTEN pathway
sensitizes cervical cancer to cisplatin. Arch Biochem Biophys.
623–624:20–30. 2017. View Article : Google Scholar
|
|
31
|
Du G, Gao D and Meng L: miR-21 inhibitor
suppresses cell proliferation and colony formation regulating the
PTEN/AKT pathway and improves paclitaxel sensitivity in cervical
cancer cells. Mol Med Rep. 15:2713–2719. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Su K, Wang CF, Zhang Y, Cai YJ, Zhang YY
and Zhao Q: miR-940 upregulation contributes to human cervical
cancer progression through p27 and PTEN inhibition. Int J Oncol.
2017.(Epub ahead of print). View Article : Google Scholar
|
|
33
|
Wang H and Gao W: DJ-1 expression in
cervical carcinoma and its effects on cell viability and apoptosis.
Med Sci Monit. 22:2943–2949. 2016. View Article : Google Scholar : PubMed/NCBI
|
